We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Antisoma | LSE:ASM | London | Ordinary Share | GB0055696032 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.325 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/1/2011 13:58 | In the 2010 accounts they received £19.7 million being part of the USD 60 million due from sanofi-aventis for the divestment of oral fludarabine, any more to come? Edit "five further payments of USD 1 million will be made on each of the first five anniversaries of the signature of the sale agreement " | zulu001 | |
31/1/2011 13:56 | It is finished only idiots holding now. You in Doc | clubman | |
31/1/2011 13:53 | The amount of shorting going on here is bound to lead to a scramble for shares. The price will surely go towards 4p. | ajmace | |
31/1/2011 13:52 | Comedy - clubman, you clearly have no clue. | the_doctor2 | |
31/1/2011 13:44 | insolvent with £23m cash ? | joeblogg2 | |
31/1/2011 13:43 | Very clear and maybe they are trading insolvent or will be when sub 2p | clubman | |
31/1/2011 13:37 | eh? why? no need at all. The situation is clear. | the_doctor2 | |
31/1/2011 13:31 | Suspension looming before the end of the day IMHO | clubman | |
31/1/2011 13:28 | Daytraders - 31 Jan'11 - 13:00 - 5436 of 5444 robandkerry - looks like they dont want to pay even 1.5p now, they removed the order. Its still there DT, its just gone further down the book, as smaller higher priced orders have gone in above it. | robandkerry | |
31/1/2011 13:26 | Filbert - I tend to agree, sadly for the staff there. | the_doctor2 | |
31/1/2011 13:21 | US (Cambridge) employees will be 'at will', and therefore should be able to be made redundant at minimal cost. | filbert3 | |
31/1/2011 13:14 | from iii - conference call Short and sweet conference call covering the bad news. Confirmed cash position of £23.4M as of end of December. AS1413 program terminated. AS1411 back to investigative phase. Smaller organisation with impact on Cambridge & London facilities. Currently 60 employees . Need one month for orderly closedown. No ongoing clinical programs confirmed (as I understood it). | newswseller | |
31/1/2011 13:14 | That is all I can see and have increased my holding slightly which wasn't much in the first place as I moved it all to AKT. Just hope that comes good!!! | joeblogg2 | |
31/1/2011 13:13 | Or liquidate. All staff should be made redundant (inc the CEO) as of today other than those absolutely required to fulfill any minimum legal obligations relating to the now terminated trials. That should require about 3 people in my view - CFO to wind up, an admin person to help, and a regulatory/clin ops person for remaining legal obligations re terminated trials. | filbert3 | |
31/1/2011 13:10 | The trouble IMO is that there's not enough business left to warrant the investment ie. admin costs are too high vs the returns from pre-clin products so, options: get in more PI, PIIa, late pre-clin products or M&A to get a buyer for the cash - easier for them than a placing in some respects | the_doctor2 | |
31/1/2011 13:07 | Really awful news today!! What's left is : DCAMs (dendritic cell autoimmune modulators), a programme of small-molecule kinase inhibitors in preclinical development with potential as oral therapeutics for autoimmune diseases, and * PPMID, a new and highly targeted approach to cancer treatment under preclinical development in a collaboration with The Institute of Cancer Research. So question is is it worh pursuing these or too risky considering the results of the other trials. They might as well merge with someone with better prospects and use the cash that way as above will be a long way down the road!! | joeblogg2 | |
31/1/2011 13:05 | The trading before suggests this didnt leak | the_doctor2 | |
31/1/2011 13:00 | robandkerry - looks like they dont want to pay even 1.5p now, they removed the order. | daytraders | |
31/1/2011 12:59 | My sympathies to long term holders . I learnt my lesson with Alizyme (lost a hugh amount) & Oxford biomed (don't know if they will succeed ) ,was very badly burnt.GL | hamlins | |
31/1/2011 12:55 | lets hops the US dont sale also, when they open at 2.30pm | daytraders | |
31/1/2011 12:41 | Well here goes the mid day trades down to 2p and less. I have hardly known a share to drop so fast apart from insolvency but then the shares would be suspended prior to a critical anouncement. A hard pill to swallow. | whyme | |
31/1/2011 12:39 | No probs robandkerry.I didn't explain it very well... | duncandisorderly | |
31/1/2011 12:38 | Daytraders - 31 Jan'11 - 12:32 - 5427 of 5429 well someone just put 5million shares on the buy side at 1.5p, not sure there get that low today. They will soon take that off when it goes sub 2p. :) | robandkerry | |
31/1/2011 12:38 | Filbert,totally agree.I would of thought any company with a little bit of know how and I don't necessarily mean bio could snap this up,get rid off all the staff and have the remaining products for free plus earn a few million for their troubles.I know for a fact that they have in excess of 20 million to date. | duncandisorderly | |
31/1/2011 12:35 | Sorry Duncan. I thought you were talking about pis. :) | robandkerry |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions